ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ATHA announcements Athira Pharma Inc announcements and dividends declared NASDAQ

Athira Pharma Inc Complete list of announcements declared & dividend announcements by Athira Pharma Inc ATHA

Athira Pharma Inc ATHA listed on NASDAQ and deals in

Announcements and dividends declared by Athira Pharma Inc ATHA

Mizuho Maintains Athira Pharma (ATHA) Buy Recommendation
Fintel reports that on May 15, 2023, Mizuho maintained coverage of Athira Pharma (NASDAQ:ATHA) with a Buy recommendation.
Announcement as on 15 May 2023

Athira Pharma stock loses two-thirds of its value after study of Alzheimer's treatment misses primary endpoint
Shares of Athira Pharma Inc. plummeted 66.9% toward a record low in active afternoon trading Wednesday, enough to make them the biggest decliners trading on major market indexes, after the biopharmaceutical company said a Phase 2 study of its Alzheimer's
Announcement as on 22 June 2022

Athira Pharma prices upsized IPO at , high end of price range
Athira Pharma Inc. priced its initial public offering at a share, the top end of its proposed price range. The company upsized the deal to 12 million shares from an original plan to offer 10 million shares, to raise 4 million. The stock will start
Announcement as on 18 September 2020

Athira Pharma's stock jumps at its open, with the first trade 17% above the IPO price
Shares of Athira Pharma Inc. rallied in their public debut, as the first trade was 17.4% above the initial public offering price. The Seattle-based biopharmaceutical company's upsized IPO priced late Thursday at share, at the top of the expected range
Announcement as on 18 September 2020

Athira Pharma to raise up to 0 million in IPO
Athira Pharma Inc. set terms Monday for its initial public offering, in which the the biopharmaceutical company focused on developing treatment for neurological diseases, including Alzheimer's disease, can raise up to 0 million and be valued at up to a
Announcement as on 14 September 2020

Announcements by Athira Pharma Inc first page | Next page |

ATHA Athira Pharma Inc current price & indicator signals

Moving Averages for Athira Pharma Inc

  • 5Day Average: 3.94
  • 12Day Average: 3.95
  • 20Day Average: 4.17
  • 50Day Average: 4.14
  • 100Day Average: 2.78
  • 150Day Average: 1.96
  • 200Day Average: 1.54

ATHA Indicators & signals

Indicator MACD (12,26,9)

4.03, 4.08, -0.03
Indicator MACD is in negative zone

Indicator ADX (14)

6.67, 28.57, 25
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 58
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ATHA Athira Pharma Inc are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
17 Wed Dec 2025 4.14 3.90 to 4.17 6.7% 1.94 times
16 Tue Dec 2025 3.88 3.80 to 3.95 0.78% 1.16 times
15 Mon Dec 2025 3.85 3.85 to 4.05 -0.52% 0.6 times
12 Fri Dec 2025 3.87 3.86 to 4.13 -2.03% 1.34 times
11 Thu Dec 2025 3.95 3.92 to 4.12 -0.25% 1.53 times
10 Wed Dec 2025 3.96 3.96 to 4.34 -1.25% 0.74 times
09 Tue Dec 2025 4.01 3.84 to 4.03 3.35% 0.9 times
08 Mon Dec 2025 3.88 3.87 to 3.92 -1.77% 0.25 times
05 Fri Dec 2025 3.95 3.83 to 3.96 1.28% 0.77 times
04 Thu Dec 2025 3.90 3.81 to 3.97 1.3% 0.62 times
03 Wed Dec 2025 3.85 3.83 to 4.13 -8.33% 2.07 times
02 Tue Dec 2025 4.20 4.03 to 4.50 -1.18% 1.64 times

Videos related to: ATHA announcements Athira Pharma Inc announcements and dividends declared NASDAQ

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

ATHA announcements Athira Pharma Inc announcements and dividends declared NASDAQ

 

Back to top